CARRIE LEISTER: Open Payments
NPI 1326034539 · STOW, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 24 payments from 13 companies in 2025. Trend: 2023 $365 · 2024 $497 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Lundbeck LLC | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $43 |
| ABBVIE INC. | 2 | $43 |
| Astellas Pharma US Inc | 2 | $41 |
| Organon LLC | 2 | $40 |
| Novo Nordisk Inc | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: REXULTI, TRELEGY ELLIPTA, Veozah, NEXPLANON, AIRSUPRA, UBRELVY, FARXIGA, ELIQUIS.
Industry payments across OH — which companies pay providers there.
